Terms: = Endocrine gland cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Prognosis
18 results:
1. The Senescence-Related Signature Predicts prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic cancer.
Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C
Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628
[TBL] [Abstract] [Full Text] [Related]
2. High co-expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer.
Wu X; Shen S; Qin J; Fei W; Fan F; Gu J; Shen T; Zhang T; Cheng X
BJOG; 2022 Nov; 129 Suppl 2(Suppl 2):40-49. PubMed ID: 36485069
[TBL] [Abstract] [Full Text] [Related]
3. Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study.
Kuji S; Harada M; Yoshioka N; Kajiyama H; Satoh T; Mikami M; Shozu M; Enomoto T; Osuga Y; Suzuki N
J Obstet Gynaecol Res; 2022 Mar; 48(3):806-816. PubMed ID: 34951514
[TBL] [Abstract] [Full Text] [Related]
4. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
Wang T; Tian K; Ji X; Song F
Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
[TBL] [Abstract] [Full Text] [Related]
5. Ultrasound-based radiomics score: a potential biomarker for the prediction of progression-free survival in ovarian epithelial cancer.
Yao F; Ding J; Hu Z; Cai M; Liu J; Huang X; Zheng R; Lin F; Lan L
Abdom Radiol (NY); 2021 Oct; 46(10):4936-4945. PubMed ID: 34120235
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors for incomplete response in thyroid microcarcinoma: an analysis of initial response to therapy in 517 patients.
Faro FN; Simões VRF; Ricardo GP; Cabral CP; de Cássia Braga Ribeiro K; Scalissi NM; Cury AN; Marone MM; do Prado Padovani R; Ferraz C
Arch Endocrinol Metab; 2021 Oct; 65(5):579-587. PubMed ID: 33740337
[TBL] [Abstract] [Full Text] [Related]
7. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma.
Li C; Dong Q; Che X; Xu L; Li Z; Fan Y; Hou K; Wang S; Qu J; Xu L; Wen T; Yang X; Qu X; Liu Y
BMC Cancer; 2018 Jun; 18(1):681. PubMed ID: 29940895
[TBL] [Abstract] [Full Text] [Related]
9. Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: An analysis of safety and efficacy.
Hua YQ; Wang P; Zhu XY; Shen YH; Wang K; Shi WD; Lin JH; Meng ZQ; Chen Z; Chen H
Pancreatology; 2017; 17(6):967-973. PubMed ID: 29129384
[TBL] [Abstract] [Full Text] [Related]
10. Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic cancer.
Usón Junior PLS; Callegaro-Filho D; Bugano DDG; Moura F; Maluf FC
J Gastrointest Cancer; 2018 Dec; 49(4):481-486. PubMed ID: 28924968
[TBL] [Abstract] [Full Text] [Related]
11. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
Tang H; Wei P; Chang P; Li Y; Yan D; Liu C; Hassan M; Li D
Int J Cancer; 2017 Aug; 141(4):678-686. PubMed ID: 28470677
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
Geng Y; Qi Q; Sun M; Chen H; Wang P; Chen Z
Eur J Surg Oncol; 2015 Nov; 41(11):1508-14. PubMed ID: 26343824
[TBL] [Abstract] [Full Text] [Related]
14. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.
Li X; Guo X; Li H; Lin H; Sun Y
Tumour Biol; 2014 Jun; 35(6):5281-6. PubMed ID: 24510349
[TBL] [Abstract] [Full Text] [Related]
15. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai cancer Registry 2004-2009.
Luo J; Xiao L; Wu C; Zheng Y; Zhao N
PLoS One; 2013; 8(10):e76052. PubMed ID: 24130758
[TBL] [Abstract] [Full Text] [Related]
16. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis.
Gui JC; Yan WL; Liu XD
Clin Exp Med; 2014 May; 14(2):225-33. PubMed ID: 23456571
[TBL] [Abstract] [Full Text] [Related]
17. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.
Avril S; Hahn E; Specht K; Hauptmann S; Höss C; Kiechle M; Höfler H; Schmalfeldt B
Gynecol Oncol; 2012 Dec; 127(3):516-24. PubMed ID: 23000388
[TBL] [Abstract] [Full Text] [Related]
18. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings.
Park YJ; Kim YA; Lee YJ; Kim SH; Park SY; Kim KW; Chung JK; Youn YK; Kim KH; Park DJ; Cho BY
Head Neck; 2010 Jan; 32(1):38-45. PubMed ID: 19475551
[TBL] [Abstract] [Full Text] [Related]
